Event Type
Disclosure
Mandatory
Variant
8-K
. Entry into a Material Definitive Agreement. Warrant Inducement Agreement On December 5, 2025, Medicus Pharma Ltd. (the "Company") entered into an inducement o
. The Company expects to issue the New Warrants in reliance on the exemption from the registration requirements of the Securities Act, provided by Section 4(a)(
and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be inco
. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 4.1 Form of Series C Warrant 4.2 Form of Series D Warrant 10.1 Form of Warrant Indu